Neuroplasticity and Rehabilitation: Examples in Parkinson Disease and Pediatrics Using the LSVT LOUD® and LSVT BIG® Treatment Protocols #538

TUE 1 NOV // 1:30 PM – 5:30 PM

Primary Content Focus: Neuroplasticity (includes neuroscience)

Secondary Content Focus: Neurodegenerative disease (e.g., MS, Parkinson’s disease)
Geriatric Rehabilitation,Pediatric Rehabilitation

This seminar will review and define key principles that drive activity-dependent neuroplasticity; demonstrate how these principles can be integrated into defined, evidenced-based treatment protocols (using LSVT LOUD and LSVT BIG as example protocols); and discuss behavioral and neural outcome data from LSVT LOUD and LSVT BIG protocols in people with Parkinson disease and the LSVT LOUD protocol in children with cerebral palsy. Participants will also learn from our most up-to-date delivery strategies and use of treatment technology (telehealth, software) to make neuroplasticity-principled approaches feasible in the real-world clinical environment.

LEARNING OBJECTIVES

Identify and define at least two principles of practice that drive activity-dependent neuroplasticity and may be important to integrate into speech treatment approaches for adults and children with motor speech disorders
Explain how LSVT LOUD and LSVT BIG incorporate principles of neuroplasticity into the key treatment concepts of target, mode and calibration
Summarize the behavioral and neural outcome data that may support evidence of neuroplasticity in adults with Parkinson disease and children with cerebral palsy following LSVT protocols
Explain how technology (telehealth, software) has the potential to make neuroplasticity-principled approaches feasible in the real-world clinical environment

KEY WORDS

Neuronal Plasticity
Parkinson Disease
Cerebral Palsy
Speech Therapy
Physical Therapy

FACULTY

Cynthia Fox, PhD, CCC-SLP
Co-Founder, VP of Operations, LSVT Global, Inc.

Dr. Fox received her doctorate degree in Speech and Hearing Sciences from the University of Arizona, Tucson. She is an expert on rehabilitation and neuroplasticity and the role of exercise in the improvement of function consequent to neural injury and disease. Dr. Fox is a leader in administration of LSVT LOUD speech treatment for people with Parkinson disease (PD). She was the first to apply this treatment to other disorders, such as multiple sclerosis and pioneered the application to pediatric populations. Dr. Fox has worked closely on the development of a physical therapy program – LSVT BIG – that was modeled after LSVT LOUD. Dr. Fox is a research associate at the National Center for Voice and Speech and Co-founder and VP of Operations at LSVT Global, Inc.

Carol Boliek, PhD
Professor in the Department of Communication Sciences and Disorders, University of Alberta

Dr. Boliek, is a professor in the Department of Communication Sciences and Disorders, University of Alberta. She has investigated breathing and vocalization in infants and young children who are typically developing and those with motor speech disorders. She is currently examining activity-dependent neuroplasticity and speech motor control in children.

Laura Gusé, MPT, MSCS

Chief Clinical Officer of LSVT BIG for LSVT Global, Inc.

Ms. Gusé received her Master’s Degree in Physical Therapy from the University of North Dakota. Ms. Gusé has worked extensively in the area of neurogenic disorders since then, both in outpatient and inpatient settings. She has specialized in treatment of Parkinson disease and Multiple Sclerosis. She has been certified in LSVT BIG® since 2009, and is a Multiple Sclerosis Certified Specialist. She has been an LSVT BIG instructor for 5 years, training thousands of clinicians across the globe in the delivery of LSVT BIG. Ms. Gusé has helped to develop and publish many of the current LSVT BIG treatment tools, webinars and curriculum the LSVT BIG workshops. She now serves as the Chief Clinical Officer of LSVT BIG for LSVT Global, Inc.